Abstract Aging is a complex biological process characterized by progressive functional decline across tissues and increased susceptibility to age-related diseases, with oxidative stress being a key contributing factor
Proposed Mechanism BPC-157 appears to work through multiple pathways: Maintaining vesicular integrity (affecting VMATs and dopamine transporters) Possibly occupying its own vesicular storage sites Competing for dopamine receptor binding Functionally substituting when dopaminergic neurons are lost This last property, essentially filling in for missing dopamine function, would explain why the peptide counteracts both receptor agonists (apomorphine) and antagonists (haloperidol, fluphenazine, clozapine, sulpiride) with equal effectiveness
The exact dose depends on the patients B12 levels, any health issues, and how well they respond to treatment
Potencial neuroprotector: En modelos animales parece ayudar en la recuperacin de lesiones neurolgicas, aunque esto est lejos de estar demostrado en humanos
Unlocking Parkinsons disease: the role of microRNAs in regulation, diagnosis, and therapy